Page last updated: 2024-08-25

nagilactone c and Aortic Diseases

nagilactone c has been researched along with Aortic Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, F; Gui, Y; Hu, L; Li, H; Wang, Y; Xi, C; Yan, H; Yao, S; Ye, Y; Yu, C1

Other Studies

1 other study(ies) available for nagilactone c and Aortic Diseases

ArticleYear
A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
    Cardiovascular research, 2016, Volume: 112, Issue:1

    Topics: Animals; Aorta; Aortic Diseases; Apolipoprotein A-I; Apolipoproteins E; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; Binding Sites; Cell Line, Tumor; Cholesterol, HDL; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Genetic Predisposition to Disease; Humans; Hypolipidemic Agents; Liver X Receptors; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Phenotype; Plaque, Atherosclerotic; Promoter Regions, Genetic; RAW 264.7 Cells; RNA Interference; Signal Transduction; Transfection

2016